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Aims The aim of the present study was to describe a 10 years single-centre experience in pacing and deﬁbrillating leads
removal using an effective and safe modiﬁed mechanical dilatation technique.
Methods
and results
We developed a single mechanical dilating sheath extraction technique with multiple venous entry site approaches.
We performed a venous entry site approach (VEA) in cases of exposed leads and an alternative transvenous femoral
approach (TFA) combined with an internal transjugular approach (ITA) in the presence of very tight binding sites
causing failure of VEA extraction or in cases of free-ﬂoating leads. We attempted to remove 2062 leads [1825
pacing and 237 implantable cardiac deﬁbrillating (ICD) leads; 1989 exposed at the venous entry site and 73 free-
ﬂoating] in 1193 consecutive patients. The VEA was effective in 1799 leads, the TFA in 28, and the ITA in 205; in
the overall population, we completely removed 2032 leads (98.4%), partially removed 18 (0.9%), and failed to
remove 12 leads (0.6%). Major complications were observed in eight patients (0.7%), causing three deaths (0.3%).
Conclusion Mechanical single sheath extraction technique with multiple venous entry site approaches is effective, safe, and with a
good cost effective proﬁle for pacing and ICD leads removal.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
In recent years, the signiﬁcantly expanded use of implanted devices
for cardiac pacing and deﬁbrillation has increased the number of
device-related complications and, consequently, the need for
removal.
1–4Over the past two decades, although extraction tech-
niques have evolved from simple traction to extraction with
dilators
5–11 and powered sheaths
12–20 with reported success
rates over 95%, percutaneous lead removal has still been associ-
ated with a small but signiﬁcant procedural failure, morbidity, and
mortality.
As known, ﬁbrotic tissue develops over time and entraps the
implanted lead in the veins and in the cardiac chambers.
However, conventional techniques including the use of a locking
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lead removal through the venous entry site
19 are sometimes not
able to overcome common procedural difﬁculties, causing failure
and/or complications.
According to these observations, since 1997 we have been
developing a modiﬁed percutaneous mechanical dilatation tech-
nique
21–23 to improve success rate and to reduce complications.
The aim of this study is to report the results obtained in a series
of consecutive patients over a period of more than 10 years.
Methods
Population
Between January 1997 and June 2007, all consecutive patients admitted
to our Institution for lead extraction were evaluated. The clinical and
pacing notes of all patients were examined and relevant data were
entered into a structured database and then evaluated.
Patients referred to our Institution were accepted for transvenous
lead extraction and prepared for the intervention according to the cur-
rently used guidelines.
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Extraction procedure
The procedures were performed in the cardiac electrophysiology lab-
oratory, with cardiothoracic surgery standby available, in a fasting state
after obtaining informed consent. Before the extraction procedures,
the patients were prepared with application of cutaneous pads for deﬁ-
brillation, transvenous temporary pacing, invasive arterial blood
pressure, and pulse oximetry monitoring.
The extraction procedures were performed by three trained inter-
ventional cardiologists.
Once the patient was prepared, draped, and sedated, the pulse gen-
erator pocket was opened and the leads freed by electrocauthery from
their adhesions down to the venous insertion site or as far as possible.
The leads were cut 10–15 cm out of the venous entry site. A stiff
normal stylet supplied by the lead manufacturer, of appropriate
length for the lead, was introduced into the lead body with its tip as
close as possible to the lead tip in order to stiffen it. One or two
(in the presence of unipolar or bipolar leads, respectively) ties of silk
suture material (Ethibond Excel 0, Ethicon, Johnson & Johnson, St
Steven-Woluwe, B) were secured, respectively, around the outer
and the inner insulation of the lead. Once the lead was freed and
secured, gentle manual traction was applied in an attempt to remove
the lead. When manual traction failed to remove the lead, we used
a modiﬁed percutaneous dilatation technique.
5,8,20
(1) In the presence of leads exposed through tributary veins of the
superior vena cava system (cephalic, subclavian, jugular vein) the
venous entry site approach (VEA) was the ﬁrst choice technique.
Dilatation was performed using polypropylene sheaths by Cook
Vascular Inc. (Leechburg, PA, USA). The size of the sheaths, all
provided with bevelled ends, ranged from 7 to 14F. Dilatation
was started by using a single sheath with the inner diameter as
close as possible to the lead body diameter. Traction was main-
tained on the silk ties while the sheath was advanced under ﬂuoro-
scopy following the lead course and avoiding any angle. The
advancement of the sheath was made by rotating it alternatively
clockwise and counter-clockwise with two or three turns. While
dilating, smooth traction was performed in order to keep the
lead in tension, but avoiding myocardial wall invagination or coil
lengthening and lead damage. When the advancement of the
sheath was difﬁcult, it was retrieved for a few millimetres and dila-
tation restarted. If unsuccessful, the dilator was changed to a new
one of larger diameter. Occasionally, instead of moving to a larger
sheath, we modiﬁed the bevelled end of the dilator sheath. The
oriﬁce of the sheath was enlarged by cutting away a small
portion of the polypropylene, paying attention to avoid any modi-
ﬁcation of the distal part of the bevelled edge. Once the tip was
reached, while exerting a mild traction and maintaining the stylet
inserted till the tip, dilatation was performed by continuous clock-
wise and counter-clockwise rotation of the sheath, in order to
dissect the distal binding site, and checking by ﬂuoroscopy that
the sheath did not overcome the tip of the lead. Once the tip
was freed, the lead and the sheaths were removed through the
vein of insertion. When the lead tip was made free by traction
and dilatation before the sheath reached the distal end of the
lead, but the retrieval was impossible because of unablated
binding sites, then a transfemoral workstation was used for grasp-
ing the lead tip and to remove it, by slipping it through the binding
sites. When, despite the use of larger sheaths, dilatation was
stopped at any binding site for 5 min, or when dilatation was
judged too risky, the internal transjugular approach (ITA) was con-
sidered. To perform ITA, the transfemoral approach (TFA) was
necessary as a crossover step. Procedural steps are shown in
Figure 1. The transfemoral workstation, provided with a remote
control tip deﬂecting wire (Cook Vascular Inc., Leechburg, PA,
USA), was introduced through the right femoral vein, and
Figure 1 Consecutive steps of the internal transjugular
approach (ITA) in case of crossover from the venous entry
approach (VEA). (A) A tip deﬂecting wire is advanced via the
femoral vein in order to assess the possibility to grasp the lead
and to move it. (B) Once the lead has been grasped, it is pulled
down in the inferior vena cava and slipped through the binding
site; a Lasso, introduced through the internal jugular vein, is
advanced near the proximal end of the lead. (C) The lead is
caught by the Lasso, pulled up and exposed through the jugular
vein. (D) Dilatation using a dilating sheath is performed. See the
text for further details. TDW, tip deﬂecting wire.
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bility of slipping the lead into the blood ﬂow (Figure 1A). Using the
tip deﬂecting wire, the lead was grasped at the level of the right
atrium or superior vena cava, below the site where dilatation
was stopped. Using slight traction, the possibility of slipping the
lead and making it free-ﬂoating was assessed (Figure 1B). When
the lead could not be slipped through, the possibility of grasping
it above the binding site and making it free-ﬂoating was checked.
After the removal of the stylet and the suture, the lead was
made free-ﬂoating by traction using the tip deﬂecting wire. Then
the right internal jugular vein was percutaneously cannulated
using an 11 French introducer (Avanti þ, Cordis Corp., Miami,
FL, USA). A Lasso (Osypka GmbH, Grentzig-Whylen, Germany)
was advanced through the jugular vein, the proximal end of the
lead was captured as close as possible to its end, and the lead
was retrieved through the jugular vein and exposed (Figure 1C).
A percutaneous procedure for exposed leads using dilating
sheaths was then performed (Figure 1D).
(2) In the presence of free-ﬂoating leads (i.e. leads migrated into the
venous system, with the proximal end not accessible in the pace-
maker pocket), the TFA was the ﬁrst step of the procedure.
(a) In case of free-ﬂoating leads with free tips (leads migrated into
the venous system, distal ﬁxation site detached), an intravascu-
lar tool (Lasso, Osypka GmbH) was used to grasp the lead.
Once the lead was grabbed, the possibility of slipping it
through binding sites in the upper course was assessed. If
the lead was free, it was pulled back into the workstation
and removed; in case of adherences, dilatation was performed
using the workstation.
(b) In the presence of free-ﬂoating leads with anchored tips (i.e. leads
migrated into the venous system, with the proximal end not
accessible in the pacemaker pocket, and the tip ﬁxed in the
heart), the ITA was the ﬁrst choice approach. Procedural
steps are shown in Figure 2. The possibility to move the lead
was assessed by intravascular tools introduced using the
TFA (Figure 2A). The lead was grasped by the tip deﬂecting
wire and slipped, when possible, through the adhesions. A
Lasso was advanced via the jugular vein (Figure 2B), and the
proximal end of the lead was grasped and then exposed
through the jugular vein (Figure 2C). At this point, a percuta-
neous procedure for exposed leads using dilating sheaths
was then performed (Figure 2D). When the length of the
lead did not allow its exposure, the Lasso was used as an
extension of the lead itself, and dilatation was performed by
a dilating sheath previously inserted over Lasso’s body.
Procedural outcome was deﬁned according to the radiological
outcome: complete success (removal of the whole lead), partial (a frag-
ment of less than 4 cm is left), and failure (a signiﬁcant fragment is left,
or the procedure was stopped because of a major complication).
Complications were deﬁned according to the NASPE recommen-
dations for extraction of chronically implanted leads.
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Extraction time was deﬁned as the time since the start of traction or
dilatation to the removal of the lead.
Results
Between January 1997 and June 2007, 1193 consecutive patients
(884 males, mean age 65.7 years) were considered for transvenous
removal of 2065 leads. These leads had been implanted for a mean
period of 69.3 months (median 50 months, range 1–336, 25/75
percentile 19/108 months). Pacing leads to be removed were
1828 (724 atrial, 1032 ventricular, and 72 coronary sinus). Implan-
table cardiac deﬁbrillating (ICD) leads were 237 (223 ventricular,
12 superior vena cava, and two atrial). In the overall number of
leads, 68 pacing leads (26 atrial, 41 ventricular, and one coronary
sinus) and ﬁve ICD leads (ﬁve ventricular) were free-ﬂoating.
Data about the population and leads are summarized in Table 1.
Indications for removal were mostly infection (83.5%). Indications
are reported in Table 2.
Among the 2065 leads considered for transvenous removal at
our Centre, three free-ﬂoating fragments were judged not suitable
for transvenous techniques because they were completely
included into the venous wall, in the absence of any possible
site to grasp the lead. The remaining 2062 pacing and ICD leads
were subjected to removal procedures.
Procedural outcome for all the leads is shown in Figure 3.
Leads exposed at the venous entry site
The VEA was performed in 1989 leads (1757 pacing and 232 ICD
leads). Manual traction was effective in 285 leads (14.3%), in the
remaining 1704 mechanical dilatation was attempted. The pro-
cedure was completely successful in 1514 out of 1989 leads
(76.1%), obtaining a cumulative successive rate of 90.4%. A partial
success was obtained in 12 leads (0.6%). In 10 leads, the procedure
Figure 2 Consecutive steps of the internal transjugular
approach (ITA) in case of free-ﬂoating leads with anchored tips.
(A) A tip deﬂecting wire is advanced via the femoral vein in
order to assess the possibility to grasp the lead and to move it.
(B) Once the lead has been grasped, it is pulled down in the
inferior vena cava; a Lasso, introduced through the internal
jugular vein, is advanced near the proximal end of the lead. (C)
The lead is caught by the lasso and then pulled up and exposed
through the jugular vein. (D) Dilatation using a dilating sheath is
performed. See the text for further details. TDW, tip deﬂecting
wire; FF, free-ﬂoating lead.
M.G. Bongiorni et al. 2888was stopped due to non-infective class II indications. Among the
remaining 168 leads, the removal was completed by the TFA in 12
leads, whose tips were freed while performing dilatation (0.6%).
Crossover to the ITA was performed in 156 leads (7.8%).
Free-ﬂoating leads
Seventy-three free-ﬂoating leads were approached via the femoral
vein. Lead grasping allowed the direct removal of 16 (21.9%) leads;
57 leads were exposed through the internal jugular vein and then
subjected to dilatation. In one case, the lead was too short to be
exposed; a dilating sheath was positioned over the Lasso using
this tool as an extension of the lead. Complete removal was
achieved in all leads.
Internal transjugular approach
The ITA was performed in 57 free-ﬂoating and 156 exposed leads
as crossover from the VEA. By this approach, 205 out of 213 leads
(96.2%) were completely removed. The procedure was partially
successful in 6 (2.8%) leads and unsuccessful in 2 (0.9%). The
ITA was effective in 148 out of 156 exposed leads and in all the
57 free-ﬂoating leads. In the group of the exposed leads, the ITA
increased success rate from 90.4 to 98.5% (Figure 3). In two
patients, because of the failure to cannulate either the right or
the left internal jugular vein, we used the right subclavian vein.
Overall results
Of the overall population treated at our Centre, 2032 leads were
completely removed (98.4%) and 18 partially removed (0.9%), as
shown in Table 3. We removed 1795 out of 1989 right atrial and
ventricular pacing leads (98.2%). All the 72 left ventricular leads
(mean implant period 23.36 months, range 2–96) were completely
removed; manual traction was effective in 45 (62.5%), dilatation
was necessary in 26 (into the coronary sinus in 2), and ITA was
performed in one free-ﬂoating lead. All the 237 ICD leads were
successfully removed.
In the overall population, the mean extraction time was 20+
36 min (range 1–360).
Complications
Perioperative complications were observed in 98 patients. Major
complications were observed in eight patients (0.7%): ﬁve patients
were successfully treated and three died (0.3%). Cardiac tampo-
nade occurred in seven patients, six during VEA, and one during
ITA. Pericardial drainage was successfully performed in two
patients and surgical repair was necessary in three; one patient
died despite drainage and subsequent surgical intervention. For
one patient, transferred to another hospital after the procedure,
tamponade and death occurred 12 h later. Intraoperative
haemothorax occurred in one patient, during the removal of a
lead fractured by subclavian crush. Despite medical treatment
and pleural drainage, the patient died due to haemorrhagic shock.
In four patients, the procedure was complicated by dislodge-
ment of a functioning pacing lead and lead repositioning was
required.
Minor complications, not requiring intervention, were observed
in 86 patients (7.2%). Pericardial effusion was observed in 27 cases
and thrombosis of implant vein in 12, pulmonary embolism
occurred in 18 cases. Arrhythmias requiring cardioversion
occurred in six patients, haematoma at the pocket requiring
drainage occurred in 25; in 8 patients with local infection later
development of sepsis was observed.
No complications directly related to the femoral or jugular
venous access were observed.
................................................................................
................................................................................
Table 2 Indications for removal
Indications Leads (n)
Total class I 682
I-a Sepsis, endocarditis 612
I-b Lead inducing life-threatening
arrhythmias
24
I-c Life-threatening fragment 7
I-d Lead inducing thromboembolic events 39
Total class II 1383
II-a Pocket infection, erosion, draining sinus 1099
II-b Infection, lead suspected as the source 14
II-c Chronic pain at the pocket 3
II-d Threat to the patient by lead’s design or
failure
37
II-f Traumatic injury, lead interferes with
repair
4
II-g Necessary for the implant of new leads 181
II-h Non-functional leads in young patient 45
Total 2065
Indications are classiﬁed according to NASPE recommendations.
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Table 1 Patients and leads characteristics
Patients n ¼ 1193
Men/women 884/309
Mean age (years) 65.7
Range (years) 6–95
Leads n ¼ 2065
Mean implant time
(months)
69.3
Range (months) 1–336
Pacing leads n ¼ 1828 Atrial Ventricular CS
Exposed 698 991 71
Free-ﬂoating 26 41 1
Total 724 1032 72
ICD leads n ¼ 237 Atrial Ventricular SVC
Exposed 2 218 12
Free-ﬂoating 0 5 0
Total 2 223 12
CS, coronary sinus; SVC, superior vena cava.
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Our results compare favourably in terms of success and compli-
cation rates with previous studies reporting on the superior and
femoral approaches. With regard to the superior approach, our
complete success rate (98.4%) was higher than conventional mech-
anical experiences reported by Eckhard et al.
25 (complete success
was achieved in 81% of cases), the US lead database in 1994 (com-
plete success in 86.6%),
9 and in 1996 (complete success in 93%).
10
Even if comparison between different studies and reports are
difﬁcult, because procedural outcome and complications may be
deﬁned in different ways, our results compare favourably with
powered sheaths experiences including both laser
12,13,26 and radio-
frequency
18,27 techniques. Regarding lead removal via the femoral
approach, our results are comparable in terms of complete success
rate but with lower major complication rate, especially if a needle’s
eye snare is used for countertraction.
28,29 Furthermore, our data
are more intriguing considering the presence of deﬁbrillating and
free-ﬂoating leads and a long dwell time (median 50 months).
We think that our high success rate can be attributed to an
integrated procedural approach. Indeed, a multivenous entry site
approach (venous lead entry site, femoral and right internal
jugular vein) with a modiﬁed mechanical dilatation technique
(single sheath rotation without tip countertraction) has the advan-
tages of each approach without the most common disadvantages,
with a tailor-made procedural strategy for leads and patients.
As previously reported, common critical points in the removal
procedures include: (i) tight space between the clavicle and the
ﬁrst rib (large sheaths use precluded);
16 (ii) presence of tight
binding sites due to scar or calciﬁed tissue (difﬁcult sheath
advancement);
9,10 (iii) hard turns in the lead course (risky sheath
advancement); (iv) difﬁcult countertraction (myocardial wall invagi-
nation),
9,10 (v) lead damage (preventing the use of a stylet);
9,29 and
(vi) the presence of free-ﬂoating leads (difﬁcult to hold, insertion of
a stylet not possible).
28,29 Every technique (conventional telescop-
ing dilatation, powered sheath, and femoral approach) shows limit-
ations at the above described critical points, reducing success rate
and increasing complications as described in Table 4.
Figure 3 Diagram summarizing the outcome of the overall leads included in the study, their management, and the ﬁnal result. ISR, incremental
success rate; NA, not applicable; VEA, venous entry approach; VES, venous entry site.
...............................................................................................................................................................................
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Table 3 Procedural patients and leads overall outcome
Removal A and RV PL LV PL ICD L Total %
Complete 1723 72 237 2032 98.4
Partial 18 – – 18 0.9
Failed 12 – – 12 0.6
TLR not applicable 3 – – 3 0.2
Complications Tamponade Hemothorax
Major 7 1 8 0.7
Fatal 2 1 3 0.3
Not fatal 5 – 5 0.4
TLR, transvenous lead removal; A, atrial; RV, right ventricular; LV, left ventricular.
PL, Pacing leads; ICD, implantable cardioverter deﬁbrillator; L, leads.
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holding of the lead, freeing the binding sites by dilatation all the way
to the tip and retrieving the lead through a vascular approach. In
our opinion, the key point for a successful removal is to free the
lead from all the adhesions all over its course, instead of freeing
the lead tip, so that traction at the tip is not crucial anymore.
The key point for safety, in the presence of leads difﬁcult to
remove, is to adapt the technique to the speciﬁc situation, chan-
ging, for example, the venous approach. In our opinion, high
success and low complication rates are achieved by avoiding the
use of excessive force or powered sheaths to overcome tight
binding sites. By the ITA approach, dilatation of dangerous
venous binding sites can actually be avoided in many instances as
the leads can be retrieved by sliding them down through the
scar tissue; only distal or intramyocardial scar tissue has to be
dealt with from the jugular approach. According to these obser-
vations, we developed a modiﬁed mechanical dilatation approach,
including standard stylet and single sheath dilatation technique,
with crossover to TFA and ITA in case of ineffective entry site
removal.
Standard stylet
Since dissection of binding sites has to be performed by sheaths,
the lead must be made as stiff as possible in order to allow a
ﬁrm hold. As known, a locking stylet allows a strong traction of
the lead, but, sometimes, some of them may not be removed.
However, locking and traction at the lead tip (i.e. locking stylet)
is not a key point because binding sites at the tip have to be
overcome by dilatation and rotation of the sheath more than by
traction. A standard stylet and a suture, if used with a moderate
traction, can accomplish the task with a low risk of removing the
outer insulation. The other advantage of the standard stylet is
the fact that, being easily removable, it is useful when crossovers
to alternative transvenous approach are required.
Single mechanical sheath dilatation
The use of a single sheath and progressive mechanical dilatation
offers a ﬂexible extraction technique, allowing the use of smaller
sheaths. Dilatation by rotation of a single smaller sheath is effective
for most binding sites along the course of the lead, particularly at
the junction between the innominate vein and superior vena cava.
In our opinion, the tip can be freed in a safer way by clockwise and
counter-clockwise rotation of a single sheath, narrowly tailored
around the tip, in order to obtain the avulsion of the tip itself
from the scar tissue, instead of heavy traction performed while
maintaining the outer sheath against the wall.
Furthermore, the telescoping sheath, due to its larger diameter,
is stiff and more difﬁcult to advance. Failure of dilatation was
observed in the presence of calciﬁed adherences or in case of a
tortuous course of the lead. In these conditions, the use of
powered sheaths, even if more effective and faster than mechanical
ones, does not provide any advantage, increasing the risk of
complications.
15,16,30 Furthermore, even if requiring less time, the
procedure is much more expensive.
18 Our results demonstrate
that the technique of single sheath mechanical dilatation paired
with the appropriate approach in the presence of difﬁcult leads
is at least as effective as powered dilatation, with lower cost.
Multiple venous entry site approach
In our opinion, the use of a single sheath technique with the right
internal jugular approach can be a solution in most of the difﬁcult
situations previously mentioned (Table 4). First, withdrawing the
lead with a TFA, it may be slipped through some binding sites,
avoiding dilatation of some adherences (Figure 2B). Secondly,
once exposed through the jugular vein, free-ﬂoating leads and
difﬁcult leads turned into free-ﬂoating ones may be managed as
exposed leads. At this point, mechanical dilatation may be
performed via internal jugular vein avoiding some disadvantages
...............................................................................................................................................................................
Table 4 Critical points during pacing and implantable cardioverter deﬁbrillator lead removal
Critical points Problems Standard approach limitations
Tight space between
clavicle and ﬁrst rib
Difﬁcult sheath advancement Use of large sheaths (telescoping sheath, powered sheath)
often precluded
Tight binding sites Binding sites ﬁbrous and stiff, often calciﬁed, difﬁcult to free
the lead
Venous entry site mechanical dilatation needs aggressive
dilatation.Poweredsheathsare ineffectiveinthe presenceof
calciﬁed tissue
Hard turn in lead
course
In the presence of hard turns (right side implant, impossible
stylet introduction), the energy of dilatation is not applied
to the binding site, but directly on the venous wall
Telescopingandpoweredsheathsapplyexcessive dilating force
with the risk of vein damage
Difﬁcult
countertraction
The lead tip cannot be freed Countertraction by an outer telescoping sheath may result in
ventricular wall disruption and cardiac tamponade. Powered
sheaths cannot be used near the lead tip
Lead damage Insulation is absent, coil is lengthened, or stylet cannot be
inserted
Telescoping sheath and powered sheath with high energy
dilatation may cause venous tears or complete lead fracture
Free-ﬂoating leads Venous entry site approach impossible for intravascular not
exposed leads
Binding sites dilation through the transfemoral workstation is
often ineffective due to the hard turn to cross the tricuspid
valve
See text for details.
ITA, internal transjugular approach; VEA, venous entry site approach.
Single sheath lead extraction and jugular approach 2891resulting from the VEA, such as tight space between the clavicle
and the ﬁrst rib (especially if large sheaths are required) or an
unfavourable lead/venous wall angle. Indeed, using ITA we obtain
a ‘straight course dilatation’ from the jugular vein to the heart
facilitating force application up to the tip (Figures 1D and 2D).
In conclusion, our approach was highly effective considering the
characteristics of the removed leads, with a complete success rate
slightly higher (98.4%) than that reported in most of the papers
about powered dilatation
17,18,26 or TFA approach
28,29 and with a
low number of complications (0.7%). Indeed, advantages provided
by the ITA are unrelated to the energy used for dilatation but
depend on a reduced number of binding sites to dissect and on
a straighter lead course dilatation, overcoming main limitations
resulting from the VEA (such as difﬁcult large sheath advancement,
risk of venous tear in presence of lead turns, and tight binding
sites),
12,16 and of conventional TFA (difﬁcult and risky traction).
29
Study limitations
The present study reports the experience of a single centre with a
versatile technique for transvenous lead removal; it is not a pro-
spective randomized trial.
It requires an adequate training in lead removal to obtain
reproducible results. In this study, the learning curve of the
senior operator is not included. Furthermore, the right internal
jugular vein must be patent; in our experience, the vein could
not be cannulated in two out of 213 patients, in whom the
subclavian vein was an effective alternative approach.
Finally, the mean procedural time is longer than that reported
for powered dilatation and duration cannot be predicted, but
this limitation is counterbalanced by a very high success rate, a
very low risk, as well as costs reduction.
Conclusions
The importance of transvenous lead removal techniques is currently
increasing due to the rapidly rising number of implanted devices.
Removal techniques were ﬁrst introduced in clinical practice 15
years ago, and are still considered to be in evolution. Further
advances are required in order to reach a gold standard. Our
technique proved to be very effective and safe. The use of a single
sheath method for freeing binding sites and the use of the ITA
increased the effectiveness of mechanical dilatation, while avoiding
the costs related to the use of powered sheaths. This technique
reduces the incidence of serious complications, which can lead in
turn to expanded indications for transvenous lead removal.
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Pulmonary venous infarction following pulmonary vein isolation
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A 44-year-old man developed sudden-onset
shortness of breath associated with pleuritic
chest pain. He had undergone pulmonary
vein isolation for symptomatic paroxysmal
atrial ﬁbrillation 12 months earlier in another
institution. There was no CT evidence of
pulmonary emboli. CT volume-rendered
reconstruction showed a proximal stenosis of
left superior pulmonary vein (see arrow) and
an occlusion of his left lower pulmonary vein
(Panel A), as well as consolidation of his left
lower lung lobe (Panel B). He was therefore
diagnosed with pulmonary venous infarction
secondary to venous stenosis and occlusion
following pulmonary vein isolation. The patient was successfully t r e a t e dw i t ha n t i - c o a g u l a t i o na n dp u l m o n a r yv e i na n g i o p l a s t y .
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